Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Astrazeneca Ab

02 2Astrazeneca Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AAPS
Not Confirmed
arrow
arrow
AAPS
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 50mg/ml

Packaging :

Approval Date : 21/09/2018

Application Number : 20170905000017

Regulatory Info : Approved

Registration Country : Sweden

blank

02

AAPS
Not Confirmed
arrow
arrow
AAPS
Not Confirmed

Durvalumabum

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 120mg/2.4ml

Packaging :

Approval Date : 11/06/2018

Application Number : 66548

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

AAPS
Not Confirmed
arrow
arrow
AAPS
Not Confirmed

Durvalumabum

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 500mg/10ml

Packaging :

Approval Date : 11/06/2018

Application Number : 66548

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

AAPS
Not Confirmed
arrow
arrow
AAPS
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 2020-11-03

Application Number : 1181322001IP

Regulatory Info : Authorized

Registration Country : Spain

blank

05

AAPS
Not Confirmed
arrow
arrow
AAPS
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 2020-11-03

Application Number : 1181322002IP

Regulatory Info : Authorized

Registration Country : Spain

blank

06

AAPS
Not Confirmed
arrow
arrow
AAPS
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 2018-10-31

Application Number : 1181322002

Regulatory Info : Authorized

Registration Country : Spain

blank

07

AAPS
Not Confirmed
arrow
arrow
AAPS
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 2018-10-31

Application Number : 1181322001

Regulatory Info : Authorized

Registration Country : Spain

blank